LIGAND PHARMACEUTICALS INC

LIGAND PHARMACEUTICALS INC (LGND) is a publicly traded US company. Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

The company reports trailing twelve-month revenue of $56.16M and net loss of $13.35M.

Key metrics include a return on equity of -1.3%, a debt-to-equity ratio of 0.54.

Investors tracking LGND can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.